The Fetal Medicine Foundation 17th World Congress in Fetal Medicine, Athens, Greece
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • High NT
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidney
    • Skeleton
    • Tumors
    • Syndromes
    • Other
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infections
  • Labor / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

cfDNA test

  1. Analysis of no call results of NIPTS (Panorama) View pdf
  2. Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia View pdf
  3. Can total cell-free DNA in maternal plasma or serum be used to predict preeclampsia? A systematic review View pdf
  4. Cell-free DNA and contingent screening: our experience View pdf
  5. Cell-free DNA: positive predictive value for Turner syndrome is dependent on nuchal translucency measurement View pdf
  6. Cell-free fetal DNA testing in singleton in-vitro fertilisation conceptions View pdf
  7. CfDNA testing for Klinefelter syndrome View pdf
  8. Development of a non-invasive prenatal screening for fetal aneuploidies using next-generation sequencing View pdf
  9. Expanded targeted exome sequencing in fetuses with ultrasound abnormalities View pdf
  10. Fetal DNA in maternal blood in prenatal screening of aneuploidies: Preliminary study for the adoption of the test View pdf
  11. Fetal fraction of cell-free DNA and placental function in IVF/ICSI and spontaneous pregnancy View pdf
  12. Genetic analysis for a prenatal diagnosis of complex chromosomal rearrangement View pdf
  13. Haplotype-based noninvasive prenatal testing for duchenne muscular dystrophy: a pilot study in South China View pdf
  14. High resolution chromosomal microarray analysis across all indications in prenatal diagnosis: is more better? View pdf
  15. Impact of cell free DNA analysis on invasive testing in a tertiary referral Fetal Medicine Centre View pdf
  16. Isochromosome 21q is overrepresented among false-negative cell-free DNA results involving Down syndrome View pdf
  17. NIPT is it a key of prenatal diagnosis or is a complement? View pdf
  18. Non-invasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and cfDNA View pdf
  19. Non-invasive prenatal testing as a primary screening method for common foetal aneuploidies View pdf
  20. Optimal non-invasive diagnosis of achondroplasia combining ultrasonography and cfDNA analysis View pdf
  21. Statistical and preliminary cost-effectiveness analysis of noninvasive prenatal screening of 309, 996 cases View pdf
  22. The misuse of cell-free DNA by obstetricians in cases of abnormal ultrasound findings View pdf
  23. Use of target sequencing in noninvasive prenatal testing for beta thalassemia View pdf
30072486259028003037246425382612266327312981252525242712305526412471253227702485272429042772
© 2018 The Fetal Medicine Foundation